行情

NUVA

NUVA

纽瓦索器材
NASDAQ

实时行情|Nasdaq Last Sale

75.84
+1.99
+2.69%
盘后: 75.84 0 0.00% 16:08 12/13 EST
开盘
75.46
昨收
73.85
最高
76.67
最低
74.63
成交量
48.93万
成交额
--
52周最高
76.67
52周最低
43.51
市值
39.49亿
市盈率(TTM)
83.99
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NUVA 新闻

  • SVB Leerink Earlier Maintained Outperform on NuVasive, Raised Price Target to $92
  • Benzinga.1天前
  • Neogen's Food Safety Business Thrives on Ergot Alkaloids Test
  • Zacks.1天前
  • Credit Suisse cuts view on Gilead in premarket analyst action
  • Seeking Alpha - Article.1天前
  • Intersect ENT (XENT) Grows on Innovation Despite Cost Woes
  • Zacks.2天前

更多

所属板块

医疗设备、用品及经销
+0.35%
医疗设备和用品
+0.24%

热门股票

名称
价格
涨跌幅

NUVA 简况

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.
展开

Webull提供NuVasive, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。